Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.

<h4>Objectives</h4>The objective of this paper is to study under which circumstances wearable and health app users would accept a compensation payment, namely a digital dividend, to share their self-tracked health data.<h4>Methods</h4>We conducted a discrete choice experiment...

Full description

Bibliographic Details
Main Authors: Alexandra Heidel, Christian Hagist, Christian Schlereth
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0254786
id doaj-2df6af89c00246d082356186f32faeb2
record_format Article
spelling doaj-2df6af89c00246d082356186f32faeb22021-08-10T04:31:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01167e025478610.1371/journal.pone.0254786Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.Alexandra HeidelChristian HagistChristian Schlereth<h4>Objectives</h4>The objective of this paper is to study under which circumstances wearable and health app users would accept a compensation payment, namely a digital dividend, to share their self-tracked health data.<h4>Methods</h4>We conducted a discrete choice experiment alternative, a separated adaptive dual response. We chose this approach to reduce extreme response behavior, considering the emotionally-charged topic of health data sales, and to measure willingness to accept. Previous experiments in lab settings led to demands for high monetary compensation. After a first online survey and two pre-studies, we validated four attributes for the final online study: monthly bonus payment, stakeholder handling the data (e.g., health insurer, pharmaceutical or medical device companies, universities), type of data, and data sales to third parties. We used a random utility framework to evaluate individual choice preferences. To test the expected prices of the main study for robustness, we assigned respondents randomly to one of two identical questionnaires with varying price ranges.<h4>Results</h4>Over a period of three weeks, 842 respondents participated in the main survey, and 272 respondents participated in the second survey. The participants considered transparency about data processing and no further data sales to third parties as very important to the decision to share data with different stakeholders, as well as adequate monetary compensation. Price expectations resulting from the experiment were high; pharmaceutical and medical device companies would have to pay an average digital dividend of 237.30€/month for patient generated health data of all types. We also observed an anchor effect, which means that people formed price expectations during the process and not ex ante. We found a bimodal distribution between relatively low price expectations and relatively high price expectations, which shows that personal data selling is a divisive societal issue. However, the results indicate that a digital dividend could be an accepted economic incentive system to gather large-scale, self-tracked data for research and development purposes. After the COVID-19 crisis, price expectations might change due to public sensitization to the need for big data research on patient generated health data.<h4>Conclusion</h4>A continuing success of existing data donation models is highly unlikely. The health care sector needs to develop transparency and trust in data processing. An adequate digital dividend could be an effective long-term measure to convince a diverse and large group of people to share high-quality, continuous data for research purposes.https://doi.org/10.1371/journal.pone.0254786
collection DOAJ
language English
format Article
sources DOAJ
author Alexandra Heidel
Christian Hagist
Christian Schlereth
spellingShingle Alexandra Heidel
Christian Hagist
Christian Schlereth
Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.
PLoS ONE
author_facet Alexandra Heidel
Christian Hagist
Christian Schlereth
author_sort Alexandra Heidel
title Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.
title_short Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.
title_full Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.
title_fullStr Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.
title_full_unstemmed Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.
title_sort pricing through health apps generated data-digital dividend as a game changer: discrete choice experiment.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2021-01-01
description <h4>Objectives</h4>The objective of this paper is to study under which circumstances wearable and health app users would accept a compensation payment, namely a digital dividend, to share their self-tracked health data.<h4>Methods</h4>We conducted a discrete choice experiment alternative, a separated adaptive dual response. We chose this approach to reduce extreme response behavior, considering the emotionally-charged topic of health data sales, and to measure willingness to accept. Previous experiments in lab settings led to demands for high monetary compensation. After a first online survey and two pre-studies, we validated four attributes for the final online study: monthly bonus payment, stakeholder handling the data (e.g., health insurer, pharmaceutical or medical device companies, universities), type of data, and data sales to third parties. We used a random utility framework to evaluate individual choice preferences. To test the expected prices of the main study for robustness, we assigned respondents randomly to one of two identical questionnaires with varying price ranges.<h4>Results</h4>Over a period of three weeks, 842 respondents participated in the main survey, and 272 respondents participated in the second survey. The participants considered transparency about data processing and no further data sales to third parties as very important to the decision to share data with different stakeholders, as well as adequate monetary compensation. Price expectations resulting from the experiment were high; pharmaceutical and medical device companies would have to pay an average digital dividend of 237.30€/month for patient generated health data of all types. We also observed an anchor effect, which means that people formed price expectations during the process and not ex ante. We found a bimodal distribution between relatively low price expectations and relatively high price expectations, which shows that personal data selling is a divisive societal issue. However, the results indicate that a digital dividend could be an accepted economic incentive system to gather large-scale, self-tracked data for research and development purposes. After the COVID-19 crisis, price expectations might change due to public sensitization to the need for big data research on patient generated health data.<h4>Conclusion</h4>A continuing success of existing data donation models is highly unlikely. The health care sector needs to develop transparency and trust in data processing. An adequate digital dividend could be an effective long-term measure to convince a diverse and large group of people to share high-quality, continuous data for research purposes.
url https://doi.org/10.1371/journal.pone.0254786
work_keys_str_mv AT alexandraheidel pricingthroughhealthappsgenerateddatadigitaldividendasagamechangerdiscretechoiceexperiment
AT christianhagist pricingthroughhealthappsgenerateddatadigitaldividendasagamechangerdiscretechoiceexperiment
AT christianschlereth pricingthroughhealthappsgenerateddatadigitaldividendasagamechangerdiscretechoiceexperiment
_version_ 1721212861612556288